An analysis of patient-reported outcomes data from the MIRROR trial offers insight into the effects of pegloticase plus methotrexate on quality of life and various disease activity indices.
Related Keywords
Brian Lamoreaux , Health Assessment Questionnaire , European Congress , Horizon Therapeutics , Biologics License Application ,
vimarsana.com © 2020. All Rights Reserved.